NOMINATION HIGHLIGHTS

Healthcare security teams have spent years being sold IoMT device visibility. What they actually need is enforcement: the ability to translate IoMT device intelligence into policies that contain threats before they move laterally through clinical networks. Asimily’s newly expanded microsegmentation capabilities represent exactly that shift, and they arrive as a just-released KLAS Research report named microsegmentation the top priority among healthcare security leaders (and ranked Asimily the highest-scoring vendor evaluated, including for ROI).

Asimily’s IoMT risk management platform now includes Security Group Access Control List (SGACL) support within Cisco Identity Services Engine (ISE), enabling healthcare organizations to automatically apply security group policies based on Asimily’s device classification, behavioral analysis, and risk prioritization. Rather than requiring security teams to manually configure segmentation rules across heterogeneous device fleets, Asimily provides the intelligence layer that operationalizes ISE, turning deep device context into enforceable network policy at scale. The result is a direct path from discovery to risk reduction, without the manual effort that has historically made microsegmentation impractical in complex clinical environments.

This matters in healthcare because IoMT devices present a segmentation challenge unlike any other environment. Infusion pumps, imaging systems, and patient monitors often run legacy operating systems, cannot be patched on a traditional schedule, and must remain continuously available. Asimily’s approach accounts for device function, behavioral baselines, and actual exploitability to generate segmentation recommendations that are both clinically informed and operationally safe to implement.

The KLAS report validated that this approach is what buyers increasingly demand: vendors that reduce manual effort, accelerate remediation, and integrate with the broader security stack rather than requiring parallel workflows. Asimily’s platform delivers all three, with segmentation intelligence that works within existing NAC infrastructure rather than requiring organizations to rip and replace.

At Tufts Medicine, Asimily was deployed to secure more than 21,000 connected medical and IoT devices, integrating with Rapid7 InsightVM, Azure AD, and Azure Sentinel. Tufts Medicine’s CISO Brian Cayer described Asimily as a true security partner rather than a technology vendor, a distinction that reflects how completely Asimily has embedded itself into healthcare security operations.

In a sector where a single compromised device can delay care or expose an entire network, Asimily provides the precision and enforcement capability that the IoMT security category has long promised but rarely delivered.